Originally published In Press as doi:10.1074/mcp.M500021-MCP200 on March 18, 2005.
Molecular & Cellular Proteomics 4:785-795, 2005.
© 2005 by The American Society for Biochemistry and Molecular Biology, Inc.
Research
Targeted Proteomic Analysis of 14-3-3 , a p53 Effector Commonly Silenced in Cancer*,S
Anne Benzinger ,
Nemone Muster ,¶,
Heike B. Koch ,
John R. Yates, III ,¶ and
Heiko Hermeking ,||
From the Molecular Oncology, Max-Planck-Institute of Biochemistry, Am Klopferspitz 18, D-82152 Martinsried/Munich, Germany and Department of Cell Biology, The Scripps Research Institute, La Jolla, California 92037
To comprehensively identify proteins interacting with 14-3-3 in vivo, tandem affinity purification and the multidimensional protein identification technology were combined to characterize 117 proteins associated with 14-3-3 in human cells. The majority of identified proteins contained one or several phosphorylatable 14-3-3-binding sites indicating a potential direct interaction with 14-3-3 . 25 proteins were not previously assigned to any function and were named SIP226 (for 14-3-3 -interacting protein). Among the 92 interactors with known function were a number of proteins previously implicated in oncogenic signaling (APC, A-RAF, B-RAF, and c-RAF) and cell cycle regulation (AJUBA, c-TAK, PTOV-1, and WEE1). The largest functional classes comprised proteins involved in the regulation of cytoskeletal dynamics, polarity, adhesion, mitogenic signaling, and motility. Accordingly ectopic 14-3-3 expression prevented cellular migration in a wounding assay and enhanced mitogen-activated protein kinase signaling. The functional diversity of the identified proteins indicates that induction of 14-3-3 could allow p53 to affect numerous processes in addition to the previously characterized inhibitory effect on G2/M progression. The data suggest that the cancer-specific loss of 14-3-3 expression by epigenetic silencing or p53 mutations contributes to cancer formation by multiple routes.
|| Supported by the Max-Planck-Society and the Deutsche Krebshilfe/Dr. Mildred-Scheel-Stiftung (Grant 1945). To whom correspondence should be addressed. Tel.: 49-89-8578-2875; Fax: 49-89-8578-2540; E-mail: herme{at}biochem.mpg.de

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Z. HAN, K. DIMAS, X. TIAN, Y. WANG, H. HEMMI, K. YAMADA, N. KATO, P. PANTAZIS, R. J. RAMANUJAM, S. ANANT, et al.
14-3-3{sigma}-Dependent Resistance to Cisplatin
Anticancer Res,
June 1, 2009;
29(6):
2009 - 2014.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chiba, M. Tokuhara, E. H. Morita, and S. Abe
TTP at Ser245 Phosphorylation by AKT is Required for Binding to 14-3-3
J. Biochem.,
March 1, 2009;
145(3):
403 - 409.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Wu, P. Wang, L. C. Young, R. Lai, and L. Li
Proteome-Wide Identification of Novel Binding Partners to the Oncogenic Fusion Gene Protein, NPM-ALK, using Tandem Affinity Purification and Mass Spectrometry
Am. J. Pathol.,
February 1, 2009;
174(2):
361 - 370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Atkins, L. Thomas, R. T. Youker, M. J. Harriff, F. Pissani, H. You, and G. Thomas
HIV-1 Nef Binds PACS-2 to Assemble a Multikinase Cascade That Triggers Major Histocompatibility Complex Class I (MHC-I) Down-regulation: ANALYSIS USING SHORT INTERFERING RNA AND KNOCK-OUT MICE
J. Biol. Chem.,
April 25, 2008;
283(17):
11772 - 11784.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Alvarez, X. Altafaj, S. Aranda, and S. de la Luna
DYRK1A Autophosphorylation on Serine Residue 520 Modulates Its Kinase Activity via 14-3-3 Binding
Mol. Biol. Cell,
April 1, 2007;
18(4):
1167 - 1178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Bridges and G. B. G. Moorhead
14-3-3 Proteins: A Number of Functions for a Numbered Protein
Sci. Signal.,
August 9, 2005;
2005(296):
re10 - re10.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|